abstract |
A PHARMACOLOGICAL COMPOSITION TO ADMINISTER PERCUTANEOUSLY TO A HUMAN PATIENT COMPRISES A PHARMACOLOGICALLY EFFECTIVE AMOUNT OF EPERISONE, A SALT THEREOF, TOLPERISONE OR A SALT THEREOF, A WATER-SWELLABLE CROSSLINKED POLYVINYLPYRROLIDINE AND A BASE CARRIER, BEING IMPROVED IN PERCUTANEOUS ABSORPTION.(FIG. 2) |